Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma

Nadine Abi-Jaoudeh,1 Farshid Dayyani,2 Pei Jer Chen,3 Dayantha Fernando,1 Nicholas Fidelman,4 Hanna Javan,1 Po-Chin Liang,5 Jen-I Hwang,6 David K Imagawa7 1Department of Radiological Sciences, University of California Irvine, Orange, CA, USA; 2Chao Comprehensive Digestive Disease, University of Cali...

Full description

Bibliographic Details
Main Authors: Abi-Jaoudeh N, Dayyani F, Chen PJ, Fernando D, Fidelman N, Javan H, Liang PC, Hwang JI, Imagawa DK
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
phase i trial
hypoxia activated agent
hepatocellular carcinoma
image guided locoregional therapies
transarterial chemoembolization
Online Access:https://www.dovepress.com/phase-i-trial-on-arterial-embolization-with-hypoxia-activated-tirapaza-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/phase-i-trial-on-arterial-embolization-with-hypoxia-activated-tirapaza-peer-reviewed-fulltext-article-JHC

Similar Items